Gary Charles Robb Net Worth & Insider Trades
Gary Charles Robb - Chief Business Officer, Corcept Therapeutics Inc
What is Gary Charles Robb's Net Worth?
The current estimated net worth of Corcept Therapeutics Inc's Chief Business Officer, Gary Charles Robb, is estimated to be about $10.88M . Gary Charles Robb owns about 27,333 units of Corcept Therapeutics Inc common stock. In the last 7 years at Corcept Therapeutics Inc, Gary Charles Robb has sold an estimated value of $23.02M worth.
What is Gary Charles Robb's Past Insider Trading?
Gary Charles Robb's largest purchase order was 32,677 units , worth over $67.97K on July 8, 2022. Gary Charles Robb's largest sale order was 115,500 units , worth over $3.27M on February 16, 2021. In total, Gary Charles Robb has made about 32 transactions over 7 years of their time at Corcept Therapeutics Inc. Gary Charles Robb usually trades in February, with the busiest year in 2022. The most recent transaction was a sale order of 44,000 units , worth over $1.05M on May 11, 2023.
Gary Charles Robb
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Gary Charles Robb's Salary in 2020?
As Chief Business Officer of Corcept Therapeutics Inc, Gary Charles Robb has a total base salary of $474,380 . Gary Charles Robb received compensation valued at about $2,914,438 in 2020 after becoming Chief Business Officer. The vast majority of their compensation came in the form of a bonus of $321,236 , option awards of $2,118,822 , and
What is Gary Charles Robb's' Mailing Address?
- Mailing address is C/o 149 Commonwealth Drive Menlo Park CA 94025 CA
Corcept Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Joseph K. Belanoff, M.D., | 2020 | $769,567 | $744,000 | $4,237,643 | $10,892 | $5,762,102 |
| Joseph K. Belanoff, M.D., | 2019 | $707,525 | $745,290 | $3,506,155 | - | $4,958,970 |
| Joseph K. Belanoff, M.D., | 2018 | $679,792 | $477,750 | $5,157,075 | - | $6,314,617 |
| Andreas Grauer, M.D., | 2020 | $454,550 | $219,157 | $1,271,293 | $118,274 | $2,063,274 |
| Andreas Grauer, M.D., | 2019 | $362,267 | $243,720 | $3,115,335 | $78,245 | $3,799,567 |
| Hazel Hunt, Ph.D., | 2020 | $431,873 | $243,000 | $2,084,640 | - | $2,759,513 |
| Sean Maduck, | 2020 | $474,380 | $214,157 | $2,508,404 | - | $3,196,941 |
| Sean Maduck, | 2019 | $456,133 | $308,881 | $1,476,276 | - | $2,241,290 |
| Sean Maduck, | 2018 | $436,667 | $198,000 | $2,171,400 | - | $2,806,067 |
| Charles Robb, | 2020 | $474,380 | $321,236 | $2,118,822 | - | $2,914,438 |
| Charles Robb, | 2019 | $456,133 | $308,881 | $1,845,345 | - | $2,610,359 |
| Charles Robb, | 2018 | $436,667 | $237,600 | $2,171,400 | - | $2,845,667 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm
What are Corcept Therapeutics Inc's Past Insider Trades?
Corcept Therapeutics Inc's most recent insider trade came on June 7, 2023 by Joseph Douglas Lyon who sold 10,000 units worth $236K . In the last 19 years, insiders at Corcept Therapeutics Inc have sold an estimated value of $199.84M and bought an estimated value of $187.78M worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Joseph K Belanoff, Chief Executive Officer, Robert Roe, President and Secretary, and Leonard Baker Jr, Director .
CORCEPT THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||